Page last updated: 2024-08-21

hydrazine and Teratocarcinoma

hydrazine has been researched along with Teratocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahrens, JF; Chakraborty, AR; DePamphilis, ML; Jaiswal, SK; Mallon, BS; O'Connell, CE; Pera, MF; Vassilev, A	1

Other Studies

1 other study(ies) available for hydrazine and Teratocarcinoma

Article	Year
Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors. Stem cell reports, 2022, 02-08, Volume: 17, Issue:2 Topics: Animals; Apoptosis; Autophagy; Cell Line; Cell Survival; DNA; Embryonic Stem Cells; Enzyme Inhibitors; Female; G1 Phase; Humans; Hydrazines; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Pluripotent Stem Cells; Teratocarcinoma; Transplantation, Heterologous	2022

Article

Year

Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors.

Stem cell reports, 2022, 02-08, Volume: 17, Issue:2

Topics: Animals; Apoptosis; Autophagy; Cell Line; Cell Survival; DNA; Embryonic Stem Cells; Enzyme Inhibitors; Female; G1 Phase; Humans; Hydrazines; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Pluripotent Stem Cells; Teratocarcinoma; Transplantation, Heterologous

2022